With NPAT of $2.8 to 3.2M, it implies current valuation of P/E of 16 to 14. I am glad CMP's performance matches its share price. Nothing crazy about valuation. It's a relatively safe investment, in time of turbulent market.
I think spin-off is less likely, because CMP sees a lot of unlocked value in DWP/Neuroscan. With support of AUS government, it would be embarrassing to sell the division cheap.
I think CMP is looking for strategic partnership in both divisions, which are wonderful business/hidden champions.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.82M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 28.0¢ | $410 | 1.464K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 20999 | 1 |
View Market Depth
| Last trade - 10.17am 18/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |